uftoral has been researched along with Kidney Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Mitsuhata, N; Watanabe, Y | 1 |
| Hoshi, K; Ikeda, Y; Kanbara, T; Kawasaki, Y; Namima, T; Ohnuma, T | 1 |
| Hamaguchi, K; Kamura, K; Matsushita, K; Seto, K; Shiomi, K; Yamauchi, T | 1 |
| Akaza, H; Tsukamoto, S | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Kitazato, K; Miyadera, K; Okabe, S; Yonekura, K | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K | 1 |
1 review(s) available for uftoral and Kidney Neoplasms
| Article | Year |
|---|---|
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
5 other study(ies) available for uftoral and Kidney Neoplasms
| Article | Year |
|---|---|
[Renal transplantation surgery is closely linked with treatment for bilateral synchronous renal cell carcinomas or renal tumors in solitary kidney].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Female; Humans; Interferon-alpha; Kidney; Kidney Neoplasms; Kidney Transplantation; Living Donors; Male; Middle Aged; Neoplasms, Multiple Primary; Nephrectomy; Postoperative Care; Tegafur; Transplantation, Autologous; Uracil | 2004 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Nephrectomy; Pneumonectomy; Quality of Life; Remission Induction; Tegafur; Uracil | 2007 |
[Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Embolization, Therapeutic; Humans; Interferon-alpha; Kidney Neoplasms; Male; Neoplastic Cells, Circulating; Renal Artery; Tegafur; Uracil | 1997 |
[Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Drug Combinations; Endothelial Growth Factors; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Sodium Oxybate; Tegafur; Tumor Cells, Cultured; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Chemotaxis; Colonic Neoplasms; DNA Replication; Drug Combinations; Endothelial Growth Factors; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Floxuridine; Fluorouracil; Humans; Intercellular Signaling Peptides and Proteins; Kidney Neoplasms; Lung Neoplasms; Lymphokines; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasm Proteins; Neovascularization, Pathologic; Prodrugs; Prostheses and Implants; Recombinant Proteins; Sodium Oxybate; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays | 2001 |